Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period, alleging misleading statements related to a secondary stock offering and an acquisition by AbbVie Inc. [1][5] Group 1: Lawsuit Details - The class action lawsuit targets individuals or entities that sold or held Cerevel stock from October 11, 2023, to August 1, 2024, and those entitled to vote on the merger with AbbVie [1] - The lawsuit claims that during the class period, Cerevel's controlling shareholders, Bain Capital and Pfizer, made false statements regarding a secondary stock offering, which allowed Bain to acquire shares at a discounted price before AbbVie's acquisition announcement [5] - Following the secondary offering, AbbVie announced its acquisition of Cerevel for $45 per share, nearly double the offering price, resulting in Bain Capital receiving over $120 million in windfall profits [5] Group 2: Next Steps for Investors - Investors wishing to join the class action can do so without any out-of-pocket fees through a contingency fee arrangement [2] - Interested parties can visit the provided link or contact Rosen Law Firm for more information on participating in the class action [3][6] - A lead plaintiff must file a motion with the court by June 3, 2025, to represent other class members [1][3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4] - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4]

Group 1 - The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of UnitedHealth Group due to allegations of materially misleading business information [1] - UnitedHealth's stock fell 22.3% on April 17, 2025, after the company reported earnings that fell short of Wall Street's expectations and downgraded its projected results for 2025, citing issues in its Medicare business [3] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses, allowing affected shareholders to join without any out-of-pocket fees through a contingency fee arrangement [2] Group 2 - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - The founding partner of the firm was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [3]

Group 1 - Monteverde & Associates PC is investigating iCAD, Inc. in relation to its proposed merger with RadNet, Inc., where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock held at the closing of the merger [1] - Monteverde & Associates PC has a successful track record in recovering millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm operates from the Empire State Building in New York City and is a national class action securities firm with experience in trial and appellate courts, including the U.S. Supreme Court [2][3] Group 2 - The firm encourages shareholders with concerns regarding iCAD, Inc. to visit their website or contact them for additional information free of charge [3] - Monteverde & Associates PC emphasizes that no company, director, or officer is above the law, reinforcing their commitment to shareholder rights [3] - The firm provides a platform for potential clients to inquire about their litigation history and success in recovering funds for shareholders [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased HealthEquity securities [2] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] Group 2: Company Performance and Market Reaction - HealthEquity's shares fell 17% on March 19, 2025, after an article reported that the company missed profit estimates and provided weak guidance due to increased criminal activity targeting the firm [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is reminding purchasers of ICON plc ordinary shares during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors [1][2]. Group 1: Class Action Details - The Class Period for the lawsuit is from July 27, 2023, to October 23, 2024, inclusive [1]. - Investors who purchased shares during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 11, 2025 [2]. Group 2: Reasons for Selecting Rosen Law Firm - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [3]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [3]. Group 3: Allegations Against ICON plc - The lawsuit alleges that ICON made false and misleading statements regarding its business performance and client demand during the Class Period [4]. - Specific claims include that ICON suffered a material loss of business due to customer cost reductions and funding limitations, and that its service offerings were insufficient to mitigate market downturn impacts [4]. - The lawsuit also states that ICON's reported business metrics misrepresented actual client demand, leading to a significant discrepancy between reported guidance and actual performance [4].

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements, leading to potential legal consequences and financial repercussions for the company [1]. Allegations Summary - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the allegations is from March 13, 2023, to March 11, 2025 [1]. - Shareholders are encouraged to register for the class action by May 19, 2025, to participate in potential recovery [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

NEW YORK, April 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and August 29, 2024, both dates inclusive (the "Class Period"), of the important April 14, 2025 lead plaintiff deadline.So what: If you purchased Elastic securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To ...